Cancer scientists say they have engineered a new type of super-strong antibody which could be used to boost the immune systems of patients fighting the disease.

Roughly 200,000 people are diagnosed with a blood cancer on a yearly basis. Blood cancer will claim the lives of 55,000 ...

A team of researchers from Stanford University, led by Professor Michelle Monje, has discovered that CAR-T therapy may lead ...

KINGSTON — A groundbreaking innovation in cancer therapy is now available in the Limestone City thanks to the work and ...

Researchers at Karolinska Institutet have uncovered a unique ability of a special subtype of natural killer cells in the immune system, called adaptive NK cells, to remember ovarian tumors and ...

The cancer in these cells is driven by the HER2 gene (also known as ErbB2). This image shows an oral cancer cell (white) being attacked by two white blood cells (red). The tumor-fighting cells were ...

Researchers at Karolinska Institutet have uncovered a unique ability of a special subtype of natural killer cells in the immune system, called adaptive NK cells, to remember ovarian tumors and ...

Phase-I trial of HSPCAR30 therapy shows 100% response and 50% remission in CD30+ lymphoma patients with no major side effects ...

Researchers have uncovered a unique ability of a special subtype of natural killer cells in the immune system, called adaptive NK cells, to remember ovarian tumors and effectively attack them. The ...

There, a CT scan revealed the truth: an 8cm tumour lodged in her chest with some spread to her right lung. She had Hodgkin’s ...